Arizona Telemedicine Laws: Registration, Parity, Prescribing

Arizona is one of a handful of states with an out-of-state telehealth registration. Its 2021 telehealth law, HB 2454, codified at A.R.S. Title 36, Chapter 36, lets a clinician licensed elsewhere register with the matching Arizona board instead of getting licensed, requires state-regulated plans to pay for video visits at in-person rates, and counts audio-only as telehealth when video is not reasonably available. The limits are just as specific: no registration for anyone with a discipline record, an in-person or video exam for Schedule II, and audio-only payment parity that stops at behavioral health.

Licensure: registration for the discipline-free, compact for everyone else

Section 36-3603 says the chapter does not change Title 32 licensing requirements, so the default rule stands: treating a patient located in Arizona is practicing in Arizona. Section 36-3606 adds a second door. A provider not licensed in Arizona may deliver telehealth to a person in the state after registering with the Arizona board that licenses "comparable health care providers" — any profession with an Arizona counterpart board, not only physicians.

The conditions are cumulative. The applicant must hold a current, valid, unrestricted license in another state that is substantially similar to the Arizona license, and must not be "subject to any past or pending disciplinary proceedings in any jurisdiction" — the Medical Board's checklist reads that literally: past discipline disqualifies. The application lists every U.S. license held, liability coverage that extends to Arizona telehealth, and an Arizona statutory agent for service of process. Registrants must enroll in the Controlled Substances Prescription Monitoring Program before prescribing any controlled substance, consent to Arizona jurisdiction, follow Arizona scope and standard-of-care rules, report any new license restriction within five days, and file an annual report of Arizona patients and encounters. Each board sets its own fee.

Two limits define the lane: no Arizona office unless it belongs to a multistate group with at least one Arizona-licensed provider, and no in-person care in the state without a license. Registration is not required for emergency care, consultation with an Arizona-licensed provider who keeps ultimate authority, after-care for a procedure performed in person in another state, a patient's home-state primary care or behavioral health provider (the snowbird clause), or fewer than ten telehealth encounters in a calendar year.

Physicians who need an in-person footprint should use the Interstate Medical Licensure Compact; Arizona has been a member since 2016 and participates in the Physical Therapy Compact. Arizona is also a Nurse Licensure Compact state, issuing multistate licenses since January 2018, a PSYPACT participating state since July 2020, and one of the nine states where the Counseling Compact is live rather than merely enacted. The Board of Behavioral Health Examiners has its own out-of-state rule; verify it with that board.

Prescribing: telehealth exam suffices, except Schedule II

Section 36-3602(E) bars Arizona boards from requiring an in-person examination before a prescription, "except as specifically prescribed by federal law," and says a physical or mental health status examination may be conducted during a telehealth encounter. The exception is Schedule II: those drugs "may be prescribed only after an in-person or audio-visual examination and only to the extent allowed by federal and state law." Read precisely, an audio-only visit can never support a Schedule II prescription in Arizona, which matters for telepsychiatry stimulant prescribing; a live video visit can, subject to federal law.

Several Arizona prescribing rules apply to telehealth exactly as in person:

• State registration. We found no separate Arizona controlled-substance registration for practitioners. Under § 36-2522(A), a person who prescribes a controlled substance in Arizona must first hold a current license or permit as a medical practitioner, as § 32-1901 defines that term, and be a registrant under the federal Controlled Substances Act. A provider practicing under a § 36-3606 telehealth registration must also register with the Controlled Substances Prescription Monitoring Program (CSPMP) before prescribing a controlled substance to a patient in Arizona (§ 36-3606).
• PDMP. A medical practitioner who holds a DEA registration with an Arizona address is responsible for registering with the Arizona State Board of Pharmacy for CSPMP access (§ 36-2606(A)–(B)); a § 36-3606 telehealth registrant must register before prescribing a controlled substance to a patient in Arizona. Under § 36-2606(E), as amended by Laws 2026, ch. 94 (HB 2434, effective September 12, 2026), a medical practitioner must obtain the patient's twelve-month CSPMP utilization report before issuing any prescription for a Schedule II, III or IV opioid analgesic or benzodiazepine and before prescribing any subsequent refill of that prescription. The earlier start-of-treatment-and-quarterly schedule and the one-year waiver no longer apply. Exceptions in § 36-2606(G) cover a patient receiving hospice or palliative care for a serious or chronic illness; care for cancer, a cancer-related illness or condition, or dialysis; a drug the practitioner will administer; inpatient or residential treatment in a hospital, nursing care facility, assisted living facility, correctional facility or mental health facility; and courses of five days or less for an invasive or acutely painful medical or dental procedure, or for an acute injury or disease diagnosed in an emergency department (back pain excluded). Reviewing an electronic medical record that integrates CSPMP data counts as compliance (§ 36-2606(I)), and a practitioner is not in violation while the database is down or not available in a timely manner, though the practitioner must document the date and time of the attempted access (§ 36-2606(L)).
• Opioid limits. An initial prescription for a Schedule II opioid, meaning one for a patient with no Schedule II opioid prescription covering any part of the previous sixty days, is limited to a five-day supply, or a fourteen-day supply after a surgical procedure (§ 32-3248(A), (E)). The limit does not apply to a patient who has an active oncology diagnosis or a traumatic injury (not including a surgical procedure), is receiving hospice, end-of-life, palliative or skilled nursing facility care, is being treated for burns, is receiving medication-assisted treatment for a substance use disorder, or is an infant being weaned off opioids at hospital discharge (§ 32-3248(B)). Separately, a new Schedule II opioid prescription to be filled outside a health care institution may not exceed 90 morphine milligram equivalents per day, subject to the exceptions in § 32-3248.01(B) and (E); above that level, a prescriber who is not a board-certified pain physician must first consult a board-certified pain physician or, if available, a state-designated opioid assistance and referral call service, though if the consulting physician is not available within 48 hours the prescriber may prescribe the amount the patient requires and consult afterward, and any patient prescribed more than 90 MME per day must also be prescribed naloxone or another FDA-approved opioid antagonist (§ 32-3248.01(C)–(D)).
• E-prescribing. Every Schedule II opioid prescription must be transmitted electronically to the dispensing pharmacy (§ 36-2525(N)). The exceptions include faxed orders for drugs compounded for infusion, long-term care residents, and hospice patients (§ 36-2525(F)); times when the electronic prescribing or pharmacy management system is not operational or available in a timely manner, with a written order and a record of the outage; orders to be dispensed from a VA facility, a military base health facility, an Indian Health Service facility, or a tribal-owned clinic (§ 36-2525(N)); and prescriptions issued for medication-assisted treatment of a substance use disorder (§ 36-2525(O)). The Board of Pharmacy may add exceptions by rule (§ 36-2525(Q)). We found no Arizona electronic-prescribing mandate for controlled substances other than Schedule II opioids. Medicare Part D separately requires at least 70 percent of Part D Schedule II–V prescriptions to be electronic under 42 CFR 423.160, subject to exceptions and waivers.
• Abortion. Section 36-3604 prohibits using telehealth to provide an abortion.

Federal law adds a separate layer for controlled substances. Under the temporary rule DEA and HHS published December 31, 2025 (90 FR 61301), which runs through December 31, 2026, a DEA-registered practitioner may prescribe Schedule II–V controlled substances after a real-time audio-video telemedicine encounter without a prior in-person evaluation, when the rule's other conditions are met; audio-only encounters qualify only for Schedule III–V narcotic medications approved by the FDA to treat opioid use disorder. See our guide to federal telehealth laws.

Consent: verbal or written, before the first visit

Section 36-3602(A) requires the treating provider to obtain verbal or written informed consent, including by electronic means, from the patient or the patient's health care decision maker before delivering care through telehealth. Verbal consent must be documented in the record, and telehealth reports become part of the medical record.

Consent is not required in an emergency where the patient cannot give it, or for transmitting diagnostic images to a consultant. A third exception — when the interaction "does not take place in the physical presence of the patient" — is awkwardly drafted and is best read as covering provider-to-provider work, not ordinary visits. AHCCCS points back to § 36-3602, so one intake process serves both payers.

Medicaid: parity by policy, audio-only with conditions

AHCCCS, Arizona's Medicaid program, sets telehealth rules in AMPM Policy 320-I. Plans and fee-for-service programs must cover medically necessary, cost-effective services delivered by telehealth, with no geographic restrictions and only the limits that apply in person. An out-of-state provider can serve members if enrolled with AHCCCS and compliant with § 36-3606.

Live audio-video telemedicine is paid at the in-person level. Asynchronous store-and-forward is limited to nine disciplines — dermatology, radiology, ophthalmology, pathology, neurology, cardiology, behavioral health, infectious disease, and allergy/immunology — plus e-consults. Synchronous and asynchronous remote patient monitoring are covered. Audio-only is covered when video is not reasonably available because of the member's functional status, technology, or infrastructure limits, as determined by the provider, who must make video generally available to bill it; mental health and substance use disorder services by audio-only are paid at the in-person rate. The place of service on the claim is the originating site — wherever the member is, including home.

Private insurance: payment parity, with a behavioral-health asterisk

Section 20-841.09 and its parallel sections for other insurer types require state-regulated plans to cover a service delivered by telehealth if it would be covered in person and the subscriber is in Arizona. That is coverage parity. The section then adds payment parity: plans "shall reimburse health care providers at the same level of payment for equivalent services" by HCPCS code when delivered by audio-video telehealth. Audio-only counts as telehealth under § 20-841.09 only when an audio-visual encounter is not reasonably available because of the subscriber's functional status, lack of technology, or telecommunications infrastructure limits, as determined by the provider, and the subscriber requested or authorized the encounter in advance; outside behavioral health and substance use disorder services, the subscriber must also have an existing relationship with the provider or provider group (§ 20-841.09(G)(2)). When those conditions are met, behavioral health and substance use disorder services get the in-person rate, while other audio-only services must be covered when the Telehealth Advisory Committee recommends them, at a rate the statute does not fix. To bill any audio-only service, the provider must make telehealth services generally available to patients through audio, video or other electronic media (§ 20-841.09(A)(4)).

Except in an emergency, a plan may limit telehealth coverage to providers in its network (§ 20-841.09(A)(8)). The statute does not separately address prior authorization or utilization review. A plan may apply to telehealth only the limits and exclusions that apply to the same service in person, except for services that the weight of evidence or the Telehealth Advisory Committee finds inappropriate for telehealth (§ 20-841.09(A)(1)), and it may set reasonable requirements for documentation, fraud prevention, identity verification and recordkeeping that are no more restrictive or less favorable than those for in-person care (§ 20-841.09(A)(6)). Payment parity does not apply to encounters on a platform the insurer sponsors, though a plan cannot require its own platform as a condition of network participation. Cost-sharing cannot exceed the in-person amount, and a plan that waives it must make the provider whole. Network adequacy cannot be met with telehealth-only providers. The mandate reaches state-regulated plans, not self-funded employer plans — the distinction our reimbursement guide explains.

What to watch

Arizona's telehealth chapter has been stable since 2021, but the 2026 session changed the prescription-monitoring duty that telehealth prescribers follow (Laws 2026, ch. 94, effective September 12, 2026). The moving part is the Telehealth Advisory Committee, staffed by AHCCCS, which still meets, updated its audio-only code set in late 2025, and is scheduled to terminate on July 1, 2029 — its recommendations define what private plans must cover by phone. The federal side matters more: the DEA's telemedicine prescribing framework decides what the Schedule II video exception is worth, and Medicare's flexibilities shape a retiree-heavy state's economics — verify current status of both. Verify current requirements with the Arizona Medical Board, your profession's board, and AHCCCS before acting, and compare Arizona with its neighbors in the national overview.